KEGG   DRUG: Zapomeran
Entry
D12738                      Drug                                   
Name
Zapomeran (JAN/INN)
Class
Antiviral
 DG03172  COVID-19 vaccine
Remark
Therapeutic category: 6313
Efficacy
Active immunization (SARS-CoV-2)
Comment
Zapomeran is self-replicating mRNA encoding Venezuelan equine encephalitis virus RNA replicase and full length of spike protein analog of SARS-CoV-2.
Target
SARS-CoV-2 spike glycoprotein [KO:K24152]
  Pathway
ko03230  Viral genome structure
ko03262  Virion - Coronavirus
ko05171  Coronavirus disease - COVID-19
Interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6313  Viral vaccines
     D12738  Zapomeran (JAN/INN)
Drug groups [BR:br08330]
 Antiviral
  DG03172  COVID-19 vaccine
   D12738  Zapomeran
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D12738
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12738
Other DBs
CAS: 2727965-96-8
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system